{"drugs":["Mag-Gel 600","Mag-Ox 400","MagGel","Magnesium Oxide","Uro-Mag"],"mono":{"0":{"id":"354740-s-0","title":"Generic Names","mono":"Magnesium Oxide"},"1":{"id":"354740-s-1","title":"Dosing and Indications","sub":{"0":{"id":"354740-s-1-4","title":"Adult Dosing","mono":"<ul><li>Magnesium oxide is 60% elemental magnesium.<\/li><li>Each 400-mg tablet provides 19.86 mEq  and 10 mmol of elemental magnesium.<\/li><li><b>Magnesium deficiency; Prophylaxis:<\/b> 400 mg magnesium oxide (241.3 mg elemental magnesium) ORALLY daily; tolerable upper intake level for magnesium supplements: 350 mg elemental magnesium per day<\/li><li><b>Upset stomach, Acid indigestion:<\/b> 400 mg magnesium oxide (1 tablet, 241.3 mg elemental magnesium) ORALLY twice daily; MAX: 800 mg magnesium oxide (2 tablets, 482.6 mg elemental magnesium)\/24 hours; do not exceed MAX dose for longer than 2 weeks without supervision<\/li><\/ul>"},"3":{"id":"354740-s-1-7","title":"Indications","mono":"<b>Non-FDA Labeled Indications<\/b><ul><li>Magnesium deficiency; Prophylaxis<\/li><li>Upset stomach, Acid indigestion<\/li><\/ul>"}}},"3":{"id":"354740-s-3","title":"Contraindications\/Warnings","sub":[{"id":"354740-s-3-9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"354740-s-3-10","title":"Precautions","mono":"<ul><li>Gastrointestinal:<\/li><li>-- laxative effect may occur, doses more than 400 mg\/day elemental magnesium  or more than 2 tablets in 24 hours or use of maximum dose for more than 2 weeks not recommended unless instructed by physician<\/li><li>Renal:<\/li><li>-- use caution in patients with kidney disease<\/li><li>Reproductive:<\/li><li>-- use caution patients who are pregnant or nursing<\/li><li>Concomitant use:<\/li><li>may cause a drug interaction with certain prescription medications<\/li><\/ul>"},{"id":"354740-s-3-11","title":"Pregnancy Category","mono":"Magnesium: D (FDA)<br\/>"},{"id":"354740-s-3-12","title":"Breast Feeding","mono":"<ul><li>Magnesium: AAP: Maternal medication usually compatible with breastfeeding.<\/li><li>Magnesium: WHO: Compatible with breastfeeding.<\/li><li>Magnesium: Micromedex: Infant risk is minimal.<\/li><\/ul>"}]},"4":{"id":"354740-s-4","title":"Drug Interactions","sub":{"1":{"id":"354740-s-4-14","title":"Major","mono":"<ul><li>Dabrafenib (theoretical)<\/li><li>Eltrombopag (established)<\/li><li>Elvitegravir (established)<\/li><li>Ketoconazole (probable)<\/li><li>Ledipasvir (theoretical)<\/li><li>Levomethadyl (theoretical)<\/li><li>Licorice (theoretical)<\/li><li>Mycophenolate Mofetil (probable)<\/li><li>Mycophenolic Acid (established)<\/li><li>Pazopanib (theoretical)<\/li><li>Phenytoin (theoretical)<\/li><li>Raltegravir (established)<\/li><li>Rilpivirine (theoretical)<\/li><li>Vismodegib (theoretical)<\/li><\/ul>"},"2":{"id":"354740-s-4-15","title":"Moderate","mono":"<ul><li>Amprenavir (probable)<\/li><li>Atevirdine (probable)<\/li><li>Cefditoren Pivoxil (probable)<\/li><li>Chloroquine (probable)<\/li><li>Chlortetracycline (probable)<\/li><li>Ciprofloxacin (probable)<\/li><li>Dasatinib (established)<\/li><li>Delavirdine (probable)<\/li><li>Demeclocycline (probable)<\/li><li>Dicumarol (probable)<\/li><li>Digoxin (probable)<\/li><li>Dolutegravir (established)<\/li><li>Doxycycline (probable)<\/li><li>Enoxacin (probable)<\/li><li>Erlotinib (probable)<\/li><li>Felodipine (probable)<\/li><li>Fexofenadine (probable)<\/li><li>Gabapentin (probable)<\/li><li>Gemifloxacin (probable)<\/li><li>Grepafloxacin (probable)<\/li><li>Isradipine (probable)<\/li><li>Levofloxacin (probable)<\/li><li>Levothyroxine (probable)<\/li><li>Lomefloxacin (probable)<\/li><li>Methacycline (probable)<\/li><li>Minocycline (probable)<\/li><li>Moxifloxacin (probable)<\/li><li>Nicardipine (probable)<\/li><li>Nifedipine (probable)<\/li><li>Norfloxacin (probable)<\/li><li>Oxytetracycline (probable)<\/li><li>Pefloxacin (probable)<\/li><li>Potassium Phosphate (probable)<\/li><li>Potassium Phosphate, Dibasic (probable)<\/li><li>Potassium Phosphate, Monobasic (probable)<\/li><li>Quinidine (probable)<\/li><li>Rocuronium (probable)<\/li><li>Rolitetracycline (probable)<\/li><li>Sodium Phosphate (probable)<\/li><li>Sodium Phosphate, Dibasic (probable)<\/li><li>Sodium Phosphate, Monobasic (probable)<\/li><li>Sodium Polystyrene Sulfonate (probable)<\/li><li>Sparfloxacin (probable)<\/li><li>Succinylcholine (probable)<\/li><li>Tacrolimus (probable)<\/li><li>Tetracycline (probable)<\/li><li>Ticlopidine (probable)<\/li><li>Tipranavir (probable)<\/li><li>Vecuronium (probable)<\/li><li>Zalcitabine (probable)<\/li><\/ul>"}}},"5":{"id":"354740-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Gastrointestinal:<\/b>Laxative adverse reaction<br\/>"},"6":{"id":"354740-s-6","title":"Drug Name Info","sub":{"0":{"id":"354740-s-6-17","title":"US Trade Names","mono":"<ul><li>Mag-Gel 600<\/li><li>Mag-Ox 400<\/li><li>Uro-Mag<\/li><li>MagGel<\/li><\/ul>"},"2":{"id":"354740-s-6-19","title":"Class","mono":"Magnesium Supplement<br\/>"},"3":{"id":"354740-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"354740-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"11":{"id":"354740-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Oral Tablet: 200 MG, 250 MG, 400 MG, 420 MG, 500 MG<br\/><\/li><li><b>Mag-Ox 400<\/b><br\/>Oral Tablet: 400 MG<br\/><\/li><li><b>Phillips<\/b><br\/>Oral Tablet: 500 MG<br\/><\/li><li><b>Sundown Naturals Magnesium<\/b><br\/>Oral Tablet: 500 MG<br\/><\/li><li><b>Uro-Mag<\/b><br\/>Oral Capsule: 140 MG<br\/><\/li><\/ul>"},"12":{"id":"354740-s-12","title":"Toxicology","sub":[{"id":"354740-s-12-31","title":"Clinical Effects","mono":"<b>ANTACIDS <\/b><br\/>USES: Antacids are used for the treatment of heartburn, dyspepsia, gastritis, and gastroesophageal reflux. PHARMACOLOGY: These agents work by buffering hydrochloric acid in the stomach and increasing gastric pH. TOXICOLOGY: Toxicity can result from excessive bicarbonate absorption causing systemic alkalosis, or from excessive absorption of the cations in the alkaline salts (eg, calcium, magnesium, aluminum, sodium). EPIDEMIOLOGY: Exposure is common; significant toxicity is rare and generally develops from chronic excessive use rather than acute overdose. MILD TO MODERATE TOXICITY: Diarrhea or constipation can develop. Asymptomatic hypermagnesemia, hypernatremia, hypercalcemia, elevations in serum aluminum concentrations or mild volume overload may also develop after chronic excessive use. SEVERE TOXICITY: With prolonged administration and\/or excessively large doses, dysrhythmias, hypo- and hypertension, encephalopathy, acute renal failure, gastrointestinal obstruction and\/or perforation, metabolic alkalosis, fluid, electrolyte, and mineral derangements, and myopathies and osteodystrophies have been reported. Distention and\/or obstruction with perforation and hypergastrinemia have been observed with prolonged or excessive antacid administration. ADVERSE EFFECTS: Constipation or diarrhea are the most common adverse effects. <br\/>"},{"id":"354740-s-12-32","title":"Treatment","mono":"<b>ANTACIDS<\/b><br\/><ul><li>Support: MANAGEMENT OF MILD TOXICITY: No treatment is generally necessary beyond supportive care and cessation of antacid use. MANAGEMENT OF SEVERE TOXICITY: Evaluate for electrolyte abnormalities (hypernatremia, hypermagnesemia, hypercalcemia, hypophosphatemia) and volume overload and treat as necessary. Monitor ECG.<\/li><li>Decontamination: GI decontamination is not necessary because of the poor absorption from the gastrointestinal tract and lack of systemic toxicity after acute overdose.<\/li><li>Hypercalcemia: Treat with intravenous hydration; add diuretics if hypercalcemia persists.<\/li><li>Hypermagnesemia: Treat with intravenous fluids. Monitor ECG and neurologic exam (particularly deep tendon reflexes). Hemodialysis can be used to treat severe hypermagnesemia.<\/li><li>Aluminum intoxication: Generally no treatment is required beyond cessation of exposure. Deferoxamine can be used for severe aluminum intoxication, primarily in patients with renal failure.<\/li><li>Hypernatremia: Treat with intravenous hydration.<\/li><li>Congestive heart failure: Treat with nitrates and diuretics.<\/li><li>Enhanced elimination procedure: Hemodialysis can be used to correct severe hypermagnesemia or hypercalcemia but is rarely necessary.<\/li><li>Monitoring of patient: No routine laboratory studies are needed in patients with acute exposure. In patients with chronic excessive use, monitor vital signs and evaluate for clinical evidence of volume overload. Monitor fluids, serum electrolytes (including calcium, magnesium, and phosphorus), ECG, and renal function tests in symptomatic patients and those with chronic excessive use. Monitor serum aluminum concentrations in patients with encephalopathy after chronic use of aluminum containing antacids, particularly patients with renal failure.<\/li><li>Patient disposition: HOME CRITERIA: Patients with minimal GI symptoms after inadvertent exposure can be managed at home. OBSERVATION CRITERIA: Patients with deliberate self-harm exposures, persistent symptoms or long-term excessive ingestion should be sent to a healthcare facility for evaluation. ADMISSION CRITERIA: Patients with persistent electrolyte abnormalities or volume overload should be admitted.<\/li><\/ul>"},{"id":"354740-s-12-33","title":"Range of Toxicity","mono":"<b>ANTACIDS<\/b><br\/>Toxicity is very unlikely following a single acute overdose. <br\/>"}]}}}